Sofosbuvir 400 mg Suppliers & Bulk Manufacturers
Available Forms: Film-coated Tablets
Available Strengths: 400 mg
Reference Brands: Sovaldi® (EU & US)
Category: Hepatitis
Sofosbuvir 400 mg Tablets are oral direct-acting antivirals used in combination regimens for treating chronic Hepatitis C. Manufactured under EU-GMP and USFDA-compliant facilities, they are available for B2B supply, tenders, and licensing with full CTD dossiers and bioequivalence data to support registration in regulated markets.
Product Description:
Sofosbuvir Tablets are direct-acting antiviral agents (DAAs) used in combination therapy for the treatment of chronic Hepatitis C (HCV) across multiple genotypes. A nucleotide analog NS5B polymerase inhibitor, Sofosbuvir is available in 400 mg strength and forms the backbone of several pan-genotypic HCV regimens. Manufactured under EU-GMP or USFDA-approved facilities, Sofosbuvir is ideal for B2B licensing, tender supply, and distribution in regulated and semi-regulated markets. Offered with full CTD dossier, bioequivalence data, and stability studies, it supports rapid registration and commercialization in global markets. Available as a standalone API or FDF with partner molecules.
Sofosbuvir — third party manufacturing & bulk supply
Sofosbuvir 400 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Sofosbuvir is supplied as Film-coated Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Sofosbuvir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Sofosbuvir →Frequently Asked Questions
Sofosbuvir is used for the treatment of chronic hepatitis C virus (HCV) infection. It is combined with other antiviral agents to lower viral load and achieve sustained virologic response, leading to complete viral clearance.
It is made from the active ingredient sofosbuvir, an NS5B nucleotide polymerase inhibitor that blocks the replication of hepatitis C virus.
The main trade name is Sovaldi in the USA, EU, and UK, along with multiple licensed generics in India and other regions.
Sovaldi is manufactured by Gilead Sciences. Licensed generic versions are produced by several authorized manufacturers in India and other countries.
The generic name is sofosbuvir.
The primary brand name is Sovaldi, along with various licensed generic brands depending on the region.
It is manufactured by Gilead Sciences in the USA and by licensed generic manufacturers in India and other global regions.
Related Products
Thymosin Alpha 1
Strength:
1.6 mg/vial
Form: Lyophilized Powder for Injection
Reference Brands: Zadaxin® (EU & US)
View Details
Interferon Alfa-2B
Strength:
3 million IU/vial, 5 million IU/vial, 10 million IU/vial
Form: Lyophilized Powder for Injection
Reference Brands: Intron A® (EU & US), Roferon-A®(EU), Virafin (Indila)
View Details
Eltrombopag 12.5 Mg Tablet
Strength:
Tablet: 25 mg, 50 mg, 75 mg; Suspension: 12.5 mg/5 mL
Form: Tablets & Oral suspension
Reference Brands: Promacta® (US & EU); Revolade®(EU)
View Details
Human Normal Immunoglobulin
Strength:
IVIG: 5%, 10%, 16%, 20%; SCIG: 20%
Form: (IVIG) & (SCIG)
Reference Brands: Privigen®, Gamunex-C® (EU & US),Flebogamma (LATAM)
View Details
Sofosbuvir / Velpatasvir
Strength:
Sofosbuvir 400 mg + Velpatasvir 100 mg
Form: Tablet
Reference Brands: Epclusa (EU & US), Velpanat (india)
View Details
Daclatasvir/ Sofosbuvir
Strength:
Daclatasvir 60 mg + Sofosbuvir 400 mg
Form: Tablet
Reference Brands: Hepcinat Plus (India), Myhep Dvir (India)
View Details
Quick Response Guaranteed | Verified Suppliers
